[Characteristics of therapy of acute myocardial infarction in diabetes]

Area of Science:

• Cardiology
• Diabetology
• Nephrology

Context:

• Acute myocardial infarction (MI) management in diabetic patients presents unique challenges.
• Diabetics exhibit higher mortality rates following MI compared to non-diabetics.
• Pre-existing diabetic nephropathy increases risks associated with contrast-enhanced procedures.

Purpose:

• To outline optimal therapeutic strategies for acute myocardial infarction (MI) in diabetic patients.
• To emphasize the importance of timely reperfusion and guideline-adherent medical management.
• To highlight precautions necessary to mitigate renal complications during percutaneous coronary intervention (PCI).

Summary:

• Therapeutic approaches for ST-elevation MI (STEMI) and non-ST-elevation MI (NSTEMI) in diabetics largely align with non-diabetic protocols.
• Rapid reperfusion, particularly direct percutaneous coronary intervention (PCI), is critical due to elevated mortality risks in diabetics.
• Intensive drug regimens including antiplatelets, ACE inhibitors, and beta-blockers are mandatory.
• Contrast dye administration during PCI should be minimized (ideally ≤100 ml) in patients with diabetic kidney disease.
• Coronary artery bypass grafting (CABG) is often favored over PCI for severe 3-vessel disease in diabetic individuals.
• Post-MI, comprehensive coronary artery disease management and metabolic monitoring are essential.

Impact:

• Ensures timely and appropriate care for diabetic MI patients, potentially reducing mortality.
• Minimizes the risk of contrast-induced nephropathy in a vulnerable patient population.
• Guides long-term management strategies for coronary artery disease and metabolic control in survivors.